Haydn Kissick, PhD
Dr. Kissick received his PhD in Immunology from the University of Western Australia and completed his postdoctoral fellowship in Prostate Cancer Immunology at Harvard Medical School.
Dr. Kissick's research focuses on using next generation sequencing to identify mutations to be used in personalized vaccine targets for prostate cancer. Having used these techniques in mouse models to identify novel vaccine candidates targeting mutations, Dr. Kissick and colleagues found that the immune system responds effectively against these mutations. They are now evaluating vaccines targeting mutations in prostate cancer patients as personalized immunotherapeutic vaccines. He is also interested in characterizing how the immune response to cancer is impaired by inducing exhaustion in tumor-specific CD8 T-cells, and therapies to overcome this.